Stock & Company Details
Arvinas Inc $ARVN
Price:
N/A
N/A
65M
$441M
52 Week High:
N/A
10 Day Average Volume:
N/A
-36.57
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ARVN technical indicators
Latest Arvinas Inc (ARVN) indicator readings as of 2026-11-19.
ARVN's 14-day RSI is 41.3, in neutral territory. ADX reads 25.0, sitting between trending and range-bound. MACD (12, 26, 9) is -0.22, below the zero line.
Overview
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Finance Bot
Ask your questions
Start by typing a question below.